サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1370295

ゲノム市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Genomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 139 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.85円
ゲノム市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年10月15日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

市場概要：

世界のゲノム市場規模は2022年に294億米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて15%の成長率（CAGR）を示し、2028年までに688億米ドルに達すると予測しています。

ゲノミクスは、個体の機能、マッピング、構造、進化、ゲノム（遺伝子）の研究です。診断、創薬、精密医療開発、農業研究のための消耗品、システム、ソフトウェア、サービスに依存しています。アルツハイマー病、糖尿病、がんなどの疾患の調査や治療法の確定において、ヘルスケア専門家を助ける診断や予測的洞察を提供するのに役立ちます。その結果、病院、民間診療所、診断センター、研究センターにおいて、生物学的システムの研究や複雑な遺伝学的問題の解決に世界中で活用されています。

ゲノム分野における著しい進歩、大衆の間での慢性疾患や感染性疾患の有病率の増加、個別化された医薬品への嗜好の高まりは、市場の成長を後押しする主な要因です。また、非侵襲的ながん検診に基づく研究の採用が増加していることも要因のひとつと考えられます。さらに、世界人口の拡大、気候条件の変化、食糧安全保障への懸念の高まり、化学ベースの肥料の有害な影響に関する意識の広がりなどが、作物収量を向上させるためのゲノミクスの必要性を高めています。これは、有機食品に対する消費者の嗜好の変化と相まって、市場の成長に寄与しています。さらに、バイオテクノロジーの研究開発（R&D）への投資の拡大と、医療インフラや診断技術の広範な向上が相まって、市場には明るい見通しが生まれています。これとは別に、DNAの変化を特定するためのゲノミクスベースのアプリや検査の統合は、業界の投資家に有利な成長機会を提供しています。

本レポートで扱う主な質問

  • 2022年の世界ゲノム市場規模は？
  • 2023-2028年の世界ゲノム市場成長率は？
  • 世界のゲノム市場を牽引する主要因は何か？
  • COVID-19が世界のゲノム市場に与えた影響は？
  • 世界のゲノム市場の成分別区分は？
  • ゲノミクスの世界市場の用途別区分は？
  • 技術に基づくゲノミクスの世界市場内訳は？
  • エンドユーザーに基づくゲノミクスの世界市場の内訳は？
  • ゲノミクスの世界市場における主要地域は？
  • ゲノミクスの世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のゲノム市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：コンポーネント別

  • 製品別
    • 市場動向
    • 主要タイプ
      • 機器・ソフトウェア
      • 消耗品・試薬
    • 市場予測
  • サービス
    • 市場動向
    • 主要タイプ
      • コアゲノミクスサービス
      • NGSベースサービス
      • バイオマーカー翻訳サービス
      • 計算機サービス
      • その他
    • 市場予測

第7章 市場内訳：アプリケーション別

  • 機能ゲノミクス
    • 市場動向
    • 市場予測
  • エピゲノミクス
    • 市場動向
    • 市場予測
  • バイオマーカー探索
    • 市場動向
    • 市場予測
  • パスウェイ分析
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：技術別

  • シーケンス
    • 市場動向
    • 市場予測
  • マイクロアレイ
    • 市場動向
    • 市場予測
  • ポリメラーゼ連鎖反応
    • 市場動向
    • 市場予測
  • 核酸抽出と精製
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 研究センター
    • 市場動向
    • 市場予測
  • 病院・クリニック
    • 市場動向
    • 市場予測
  • 製薬・バイオ企業
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格指標

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 23andMe, Inc.
    • Agilent Technologies, Inc.
    • Bayer Aktiengesellschaft
    • BGI Genomics Co. Ltd.
    • Bio-RAD Laboratories Inc.
    • Danaher Corporation
    • Illumina Inc.
    • Oxford Nanopore Technologies
    • PerkinElmer Inc.
    • Myriad Genetics Inc.
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Genomics Market: Major Drivers and Challenges
  • Figure 2: Global: Genomics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Genomics Market: Breakup by Component (in %), 2022
  • Figure 4: Global: Genomics Market: Breakup by Application (in %), 2022
  • Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2022
  • Figure 7: Global: Genomics Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 9: Global: Genomics (Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Genomics (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: North America: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: North America: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: United States: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: United States: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Canada: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: China: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: China: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Japan: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: India: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: India: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: South Korea: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Australia: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Indonesia: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Others: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Others: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Europe: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Germany: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: France: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: France: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: United Kingdom: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Italy: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Spain: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Russia: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Latin America: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Brazil: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Mexico: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Others: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Others: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Global: Genomics Industry: SWOT Analysis
  • Figure 90: Global: Genomics Industry: Value Chain Analysis
  • Figure 91: Global: Genomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Genomics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million US$), 2023-2028
  • Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Genomics Market: Competitive Structure
  • Table 8: Global: Genomics Market: Key Players
目次
Product Code: SR112023A2246

Abstract

Market Overview:

The global genomics market size reached US$ 29.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 68.8 Billion by 2028, exhibiting a growth rate (CAGR) of 15% during 2023-2028.

Genomics is the study of the function, mapping, structure, evolution, and genomes (genes) of an individual. It relies on consumables, systems, software, and services for diagnostics, drug discovery, development of precision medicine, and agricultural research. It aids in providing diagnostic and predictive insights that help healthcare professionals in research and finalizing treatment options for diseases, such as Alzheimer's, diabetes, and cancer. As a result, it is utilized around the world in studying biological systems and solving complex genetic problems in hospitals, private clinics, diagnostic, and research centers.

Significant advancements in the genomic field, increasing prevalence of chronic and infectious disorders among the masses, and rising preferences for personalized medicines are major factors bolstering the market growth. It can also be attributed to the growing adoption of non-invasive cancer screening-based research. In addition, the expanding global population, changing climatic conditions, rising food security concerns, and spreading awareness about the harmful effects of chemical-based fertilizers are driving the need for genomics to improve crop yield. This, in confluence with the shifting consumer preferences for organic food products, is contributing to the market growth. Furthermore, expanding investments in research and development (R&D) of biotechnology, coupled with extensive improvements in medical infrastructure and diagnostic technologies, are creating a positive outlook for the market. Apart from this, the integration of genomics-based apps and tests to identify DNA alterations is offering lucrative growth opportunities to industry investors.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global genomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, application, technology, and end-user.

Breakup by Component:

Products

Instruments and Software

Consumables and Reagents

Services

Core Genomics Services

NGS-Based Services

Biomarker Translation Services

Computational Services

Others

Consumables and reagents hold the biggest market share as they aid in performing single-molecule and real-time (SMRT) sequencing.

Breakup by Application:

Functional Genomics

Epigenomics

Biomarkers Discovery

Pathway Analysis

Others

Functional genomics dominates the application segment as they help improve crop plants, human health, and livestock.

Breakup by Technology:

Sequencing

Microarray

Polymerase Chain Reaction

Nucleic Acid Extraction and Purification

Others

Sequencing exhibits a clear dominance in the market as it provides information on genetic variants that can lead to different diseases.

Breakup by End-User:

Research Centers

Hospitals and Clinics

Pharmaceutical and Biotechnology Companies

Others

Pharmaceutical and biotechnology companies hold the majority of the total market share as they help modify genes and provide a new platform for the high-throughput genetic analysis of forest trees.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America holds the majority of the global genomics market share on account of increasing preferences for personalized medicines.

Competitive Landscape:

The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are 23andMe, Inc, Agilent Technologies, Inc., Bayer AG, BGI Group, Bio-Rad Laboratories, Inc., Danaher Corporation, Illumina, Inc., Oxford Nanopore Technologies, PerkinElmer, Inc., Myriad Genetics, Inc., F. Hoffmann-La Roche Ltd, and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global genomics market in 2022?
  • 2. What is the expected growth rate of the global genomics market during 2023-2028?
  • 3. What are the key factors driving the global genomics market?
  • 4. What has been the impact of COVID-19 on the global genomics market?
  • 5. What is the breakup of the global genomics market based on the component?
  • 6. What is the breakup of the global genomics market based on the application?
  • 7. What is the breakup of the global genomics market based on the technology?
  • 8. What is the breakup of the global genomics market based on the end-user?
  • 9. What are the key regions in the global genomics market?
  • 10. Who are the key players/companies in the global genomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Genomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Products
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Instruments and Software
      • 6.1.2.2 Consumables and Reagents
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Core Genomics Services
      • 6.2.2.2 NGS-Based Services
      • 6.2.2.3 Biomarker Translation Services
      • 6.2.2.4 Computational Services
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Functional Genomics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Epigenomics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biomarkers Discovery
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pathway Analysis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Microarray
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Polymerase Chain Reaction
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nucleic Acid Extraction and Purification
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Research Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 23andMe, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Agilent Technologies, Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 BGI Genomics Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Bio-RAD Laboratories Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Danaher Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Illumina Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Oxford Nanopore Technologies
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 PerkinElmer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Myriad Genetics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Roche Holding AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis